nodes	percent_of_prediction	percent_of_DWPC	metapath
Tasosartan—CYP3A4—Everolimus—kidney cancer	0.218	0.293	CbGbCtD
Tasosartan—CYP3A4—Temsirolimus—kidney cancer	0.147	0.198	CbGbCtD
Tasosartan—CYP3A4—Pazopanib—kidney cancer	0.0773	0.104	CbGbCtD
Tasosartan—CYP3A4—Erlotinib—kidney cancer	0.0552	0.0741	CbGbCtD
Tasosartan—CYP3A4—Paclitaxel—kidney cancer	0.0505	0.0678	CbGbCtD
Tasosartan—CYP3A4—Sorafenib—kidney cancer	0.0449	0.0603	CbGbCtD
Tasosartan—CYP3A4—Vinblastine—kidney cancer	0.0443	0.0595	CbGbCtD
Tasosartan—CYP3A4—Vincristine—kidney cancer	0.0436	0.0585	CbGbCtD
Tasosartan—AGTR1—nephron—kidney cancer	0.0431	0.243	CbGeAlD
Tasosartan—AGTR2—renal system—kidney cancer	0.0378	0.213	CbGeAlD
Tasosartan—AGTR2—kidney—kidney cancer	0.0365	0.206	CbGeAlD
Tasosartan—CYP3A4—Sunitinib—kidney cancer	0.0364	0.0488	CbGbCtD
Tasosartan—CYP3A4—Doxorubicin—kidney cancer	0.0272	0.0366	CbGbCtD
Tasosartan—CYP3A4—urine—kidney cancer	0.0127	0.0714	CbGeAlD
Tasosartan—AGTR1—nephron tubule—kidney cancer	0.00931	0.0524	CbGeAlD
Tasosartan—AGTR1—renal system—kidney cancer	0.00846	0.0476	CbGeAlD
Tasosartan—AGTR1—kidney—kidney cancer	0.00818	0.046	CbGeAlD
Tasosartan—AGTR1—cortex of kidney—kidney cancer	0.00797	0.0448	CbGeAlD
Tasosartan—AGTR1—cardiac atrium—kidney cancer	0.00758	0.0426	CbGeAlD
Tasosartan—Irbesartan—JUN—kidney cancer	0.0073	0.553	CrCbGaD
Tasosartan—AGTR1—Allograft Rejection—HARS—kidney cancer	0.00343	0.0533	CbGpPWpGaD
Tasosartan—CYP3A4—renal system—kidney cancer	0.00311	0.0175	CbGeAlD
Tasosartan—CYP3A4—kidney—kidney cancer	0.003	0.0169	CbGeAlD
Tasosartan—Candesartan—PTGS1—kidney cancer	0.00211	0.16	CrCbGaD
Tasosartan—Irbesartan—PTGS1—kidney cancer	0.00211	0.16	CrCbGaD
Tasosartan—AGTR1—Allograft Rejection—LRRK2—kidney cancer	0.00197	0.0306	CbGpPWpGaD
Tasosartan—CYP3A4—Aflatoxin activation and detoxification—ACY1—kidney cancer	0.00194	0.0301	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—GRB7—kidney cancer	0.00188	0.0292	CbGpPWpGaD
Tasosartan—AGTR1—Arf6 trafficking events—CTNNA1—kidney cancer	0.00166	0.0258	CbGpPWpGaD
Tasosartan—AGTR2—Peptide ligand-binding receptors—ANXA1—kidney cancer	0.00154	0.024	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—OR4C13—kidney cancer	0.00151	0.0234	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—OR4C13—kidney cancer	0.00137	0.0212	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—PAK1—kidney cancer	0.00131	0.0204	CbGpPWpGaD
Tasosartan—AGTR2—G alpha (i) signalling events—ANXA1—kidney cancer	0.0013	0.0202	CbGpPWpGaD
Tasosartan—CYP3A4—Fatty Acid Omega Oxidation—ALDH1A1—kidney cancer	0.00122	0.0189	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—IL13—kidney cancer	0.00112	0.0175	CbGpPWpGaD
Tasosartan—AGTR1—Arf6 signaling events—MET—kidney cancer	0.00106	0.0165	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—ANXA1—kidney cancer	0.00103	0.0161	CbGpPWpGaD
Tasosartan—Candesartan—ABCB1—kidney cancer	0.00102	0.0776	CrCbGaD
Tasosartan—CYP3A4—Aflatoxin B1 metabolism—GSTM1—kidney cancer	0.000884	0.0137	CbGpPWpGaD
Tasosartan—CYP3A4—Codeine and Morphine Metabolism—ABCB1—kidney cancer	0.000818	0.0127	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—OR4C13—kidney cancer	0.000807	0.0126	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—ANXA1—kidney cancer	0.000788	0.0123	CbGpPWpGaD
Tasosartan—AGTR2—Peptide ligand-binding receptors—POMC—kidney cancer	0.000756	0.0118	CbGpPWpGaD
Tasosartan—AGTR1—Arf6 trafficking events—CDH1—kidney cancer	0.000728	0.0113	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—ABCB1—kidney cancer	0.000724	0.0113	CbGpPWpGaD
Tasosartan—CYP3A4—Irinotecan Pathway—BCHE—kidney cancer	0.000694	0.0108	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—LATS1—kidney cancer	0.000687	0.0107	CbGpPWpGaD
Tasosartan—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—kidney cancer	0.000685	0.0107	CbGpPWpGaD
Tasosartan—Losartan—ABCB1—kidney cancer	0.00066	0.05	CrCbGaD
Tasosartan—AGTR2—G alpha (i) signalling events—POMC—kidney cancer	0.000638	0.00991	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—AKAP13—kidney cancer	0.000625	0.00972	CbGpPWpGaD
Tasosartan—AGTR1—G alpha (q) signalling events—ITPR2—kidney cancer	0.000608	0.00945	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—RELA—kidney cancer	0.000588	0.00914	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—AMER1—kidney cancer	0.000584	0.00908	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—AKAP13—kidney cancer	0.000568	0.00882	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR2—kidney cancer	0.000543	0.00845	CbGpPWpGaD
Tasosartan—AGTR1—Arf6 trafficking events—CTNNB1—kidney cancer	0.000537	0.00835	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—ITPR2—kidney cancer	0.000531	0.00826	CbGpPWpGaD
Tasosartan—CYP3A4—Tryptophan metabolism—ALDH1A1—kidney cancer	0.000524	0.00814	CbGpPWpGaD
Tasosartan—AGTR1—G alpha (q) signalling events—ANXA1—kidney cancer	0.000509	0.00792	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	0.000507	0.00788	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—ANXA1—kidney cancer	0.000503	0.00782	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—OR4C13—kidney cancer	0.00049	0.00762	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—GPC3—kidney cancer	0.000489	0.00761	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CER1—kidney cancer	0.000489	0.00761	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—ITPR2—kidney cancer	0.000483	0.0075	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—kidney cancer	0.000455	0.00708	CbGpPWpGaD
Tasosartan—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	0.000448	0.00696	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—OR4C13—kidney cancer	0.000445	0.00692	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—ANXA1—kidney cancer	0.000445	0.00692	CbGpPWpGaD
Tasosartan—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	0.000432	0.00672	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MAPK3—kidney cancer	0.000426	0.00662	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SFRP2—kidney cancer	0.000416	0.00647	CbGpPWpGaD
Tasosartan—CYP3A4—Estrogen metabolism—GSTM1—kidney cancer	0.000415	0.00645	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MAPK1—kidney cancer	0.000405	0.0063	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—ANXA1—kidney cancer	0.000404	0.00629	CbGpPWpGaD
Tasosartan—CYP3A4—Estrogen metabolism—CYP1A1—kidney cancer	0.000394	0.00612	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—POMC—kidney cancer	0.000386	0.006	CbGpPWpGaD
Tasosartan—CYP3A4—Irinotecan Pathway—APC—kidney cancer	0.000377	0.00586	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—IL2—kidney cancer	0.000367	0.00571	CbGpPWpGaD
Tasosartan—CYP3A4—Xenobiotics—CYP1A1—kidney cancer	0.000362	0.00562	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—kidney cancer	0.000352	0.00547	CbGpPWpGaD
Tasosartan—CYP3A4—Tamoxifen metabolism—CYP1A1—kidney cancer	0.000348	0.00541	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000343	0.00533	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ANXA1—kidney cancer	0.000337	0.00524	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CASP2—kidney cancer	0.000335	0.00521	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—AKAP13—kidney cancer	0.000335	0.00521	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—ACY1—kidney cancer	0.000333	0.00517	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—VEGFA—kidney cancer	0.000312	0.00485	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—GRB7—kidney cancer	0.000307	0.00477	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—ITPR2—kidney cancer	0.000285	0.00443	CbGpPWpGaD
Tasosartan—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	0.00027	0.0042	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—OR4C13—kidney cancer	0.000263	0.00409	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CTNNA1—kidney cancer	0.000258	0.00402	CbGpPWpGaD
Tasosartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.000257	0.004	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—EIF4EBP1—kidney cancer	0.000257	0.00399	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HSPB1—kidney cancer	0.000257	0.00399	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—ANXA1—kidney cancer	0.000257	0.00399	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—POMC—kidney cancer	0.000246	0.00383	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PSMD7—kidney cancer	0.000239	0.00371	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—ANXA1—kidney cancer	0.000239	0.00371	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TSC1—kidney cancer	0.000239	0.00371	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—FLT1—kidney cancer	0.000231	0.0036	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—LATS1—kidney cancer	0.000224	0.00348	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—POMC—kidney cancer	0.000218	0.00339	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PAK1—kidney cancer	0.000214	0.00333	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—JUNB—kidney cancer	0.000214	0.00333	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—AKAP13—kidney cancer	0.000204	0.00317	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—POMC—kidney cancer	0.000198	0.00308	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AMER1—kidney cancer	0.00019	0.00296	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000189	0.00294	CbGpPWpGaD
Tasosartan—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	0.000186	0.00289	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—AKAP13—kidney cancer	0.000185	0.00288	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—kidney cancer	0.000184	0.00286	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	0.000182	0.00283	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IGF2—kidney cancer	0.000175	0.00273	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CDKN2B—kidney cancer	0.000175	0.00271	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—ITPR2—kidney cancer	0.000173	0.00269	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IGF1R—kidney cancer	0.00017	0.00264	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	0.000165	0.00257	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—RAF1—kidney cancer	0.000163	0.00254	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—IL2—kidney cancer	0.000161	0.00251	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GPC3—kidney cancer	0.000159	0.00248	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CER1—kidney cancer	0.000159	0.00248	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—ITPR2—kidney cancer	0.000157	0.00244	CbGpPWpGaD
Tasosartan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.00015	0.00234	CbGpPWpGaD
Tasosartan—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000148	0.0023	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—IL2—kidney cancer	0.000146	0.00228	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—ANXA1—kidney cancer	0.000145	0.00226	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HIF1A—kidney cancer	0.00014	0.00217	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TSC2—kidney cancer	0.000139	0.00216	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SFRP2—kidney cancer	0.000136	0.00211	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—KDR—kidney cancer	0.000133	0.00208	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	0.000133	0.00206	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—ANXA1—kidney cancer	0.000132	0.00205	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	0.000126	0.00196	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—POMC—kidney cancer	0.000126	0.00196	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—APC—kidney cancer	0.000123	0.00191	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—KIT—kidney cancer	0.000123	0.00191	CbGpPWpGaD
Tasosartan—AGTR1—G alpha (q) signalling events—PIK3CA—kidney cancer	0.000122	0.0019	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000122	0.00189	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	0.000119	0.00185	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—MAPK3—kidney cancer	0.000118	0.00183	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—POMC—kidney cancer	0.000117	0.00182	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—BRAF—kidney cancer	0.000116	0.0018	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—MAPK1—kidney cancer	0.000112	0.00174	CbGpPWpGaD
Tasosartan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000112	0.00174	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	0.000109	0.0017	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CASP2—kidney cancer	0.000109	0.0017	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AKAP13—kidney cancer	0.000109	0.0017	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTT1—kidney cancer	0.000107	0.00167	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—PIK3CA—kidney cancer	0.000107	0.00166	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—KRAS—kidney cancer	0.000106	0.00165	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—PTGS1—kidney cancer	0.0001	0.00156	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GRB7—kidney cancer	9.99e-05	0.00155	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PIK3CA—kidney cancer	9.72e-05	0.00151	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—RAF1—kidney cancer	9.65e-05	0.0015	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—RELA—kidney cancer	9.61e-05	0.00149	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—ERBB2—kidney cancer	9.55e-05	0.00148	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MTOR—kidney cancer	9.42e-05	0.00146	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ITPR2—kidney cancer	9.29e-05	0.00144	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	9.08e-05	0.00141	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CDKN1B—kidney cancer	8.84e-05	0.00137	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL2—kidney cancer	8.65e-05	0.00135	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCND1—kidney cancer	8.43e-05	0.00131	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CTNNA1—kidney cancer	8.42e-05	0.00131	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—JUN—kidney cancer	8.42e-05	0.00131	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HSPB1—kidney cancer	8.37e-05	0.0013	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EIF4EBP1—kidney cancer	8.37e-05	0.0013	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CTNNB1—kidney cancer	8.35e-05	0.0013	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PTEN—kidney cancer	8.14e-05	0.00127	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TSC1—kidney cancer	7.78e-05	0.00121	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PSMD7—kidney cancer	7.78e-05	0.00121	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ANXA1—kidney cancer	7.78e-05	0.00121	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FLT1—kidney cancer	7.54e-05	0.00117	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTP1—kidney cancer	7.42e-05	0.00115	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—VEGFA—kidney cancer	7.35e-05	0.00114	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	7.32e-05	0.00114	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—POMC—kidney cancer	7.11e-05	0.00111	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—JUNB—kidney cancer	6.99e-05	0.00109	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PAK1—kidney cancer	6.99e-05	0.00109	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MAPK3—kidney cancer	6.96e-05	0.00108	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTM1—kidney cancer	6.82e-05	0.00106	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MYC—kidney cancer	6.77e-05	0.00105	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	6.73e-05	0.00105	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MAPK1—kidney cancer	6.62e-05	0.00103	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	6.47e-05	0.00101	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—POMC—kidney cancer	6.46e-05	0.001	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	6.38e-05	0.000992	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—KRAS—kidney cancer	6.25e-05	0.000972	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PIK3CA—kidney cancer	5.74e-05	0.000893	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IGF2—kidney cancer	5.71e-05	0.000888	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ACY1—kidney cancer	5.69e-05	0.000884	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CDKN2B—kidney cancer	5.69e-05	0.000884	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TP53—kidney cancer	5.56e-05	0.000864	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IGF1R—kidney cancer	5.52e-05	0.000859	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—RAF1—kidney cancer	5.32e-05	0.000828	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—IL2—kidney cancer	5.26e-05	0.000817	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PDHB—kidney cancer	4.84e-05	0.000752	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—POMC—kidney cancer	4.82e-05	0.00075	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL2—kidney cancer	4.77e-05	0.000742	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CCBL1—kidney cancer	4.55e-05	0.000707	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HIF1A—kidney cancer	4.55e-05	0.000707	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TSC2—kidney cancer	4.54e-05	0.000705	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—KDR—kidney cancer	4.35e-05	0.000676	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—KIT—kidney cancer	4.01e-05	0.000623	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—APC—kidney cancer	4.01e-05	0.000623	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GLIPR1—kidney cancer	3.94e-05	0.000613	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PPAT—kidney cancer	3.94e-05	0.000613	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—MAPK3—kidney cancer	3.84e-05	0.000597	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—POMC—kidney cancer	3.81e-05	0.000593	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—BRAF—kidney cancer	3.77e-05	0.000585	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—FH—kidney cancer	3.67e-05	0.00057	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—APRT—kidney cancer	3.67e-05	0.00057	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—MAPK1—kidney cancer	3.65e-05	0.000568	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PIK3CA—kidney cancer	3.49e-05	0.000542	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—KRAS—kidney cancer	3.45e-05	0.000536	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GPC3—kidney cancer	3.45e-05	0.000536	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CA2—kidney cancer	3.35e-05	0.000521	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALAD—kidney cancer	3.27e-05	0.000508	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ST3GAL2—kidney cancer	3.19e-05	0.000496	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PIK3CA—kidney cancer	3.17e-05	0.000493	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RAF1—kidney cancer	3.14e-05	0.000489	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RELA—kidney cancer	3.13e-05	0.000487	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALDH1A1—kidney cancer	3.12e-05	0.000485	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ERBB2—kidney cancer	3.11e-05	0.000484	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MTOR—kidney cancer	3.07e-05	0.000477	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PGK1—kidney cancer	2.99e-05	0.000465	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SLC5A3—kidney cancer	2.99e-05	0.000465	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—LDHB—kidney cancer	2.93e-05	0.000456	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CDKN1B—kidney cancer	2.88e-05	0.000448	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL2—kidney cancer	2.82e-05	0.000438	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCND1—kidney cancer	2.75e-05	0.000427	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—JUN—kidney cancer	2.74e-05	0.000426	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CTNNB1—kidney cancer	2.72e-05	0.000423	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PTEN—kidney cancer	2.65e-05	0.000412	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CA9—kidney cancer	2.54e-05	0.000395	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—VEGFA—kidney cancer	2.4e-05	0.000373	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MAPK3—kidney cancer	2.27e-05	0.000352	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MYC—kidney cancer	2.2e-05	0.000343	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CRABP1—kidney cancer	2.16e-05	0.000336	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MAPK1—kidney cancer	2.16e-05	0.000335	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—KRAS—kidney cancer	2.04e-05	0.000317	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ITPR2—kidney cancer	2.01e-05	0.000312	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PIK3CA—kidney cancer	1.87e-05	0.000291	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ACHE—kidney cancer	1.83e-05	0.000285	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTT1—kidney cancer	1.83e-05	0.000285	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TP53—kidney cancer	1.81e-05	0.000281	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SCARB1—kidney cancer	1.73e-05	0.00027	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTGS1—kidney cancer	1.72e-05	0.000267	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PSMD7—kidney cancer	1.68e-05	0.000262	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—BCHE—kidney cancer	1.6e-05	0.000248	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.58e-05	0.000245	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.52e-05	0.000237	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTP1—kidney cancer	1.27e-05	0.000197	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ABCB1—kidney cancer	1.2e-05	0.000187	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTM1—kidney cancer	1.17e-05	0.000181	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.11e-05	0.000172	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—POMC—kidney cancer	8.25e-06	0.000128	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTGS2—kidney cancer	6.58e-06	0.000102	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTEN—kidney cancer	5.74e-06	8.92e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIK3CA—kidney cancer	4.05e-06	6.29e-05	CbGpPWpGaD
